Neoantigen Cancer Vaccine Clinical Trial Case Study

This case study highlights Fortrea's management of a Phase I-II clinical trial for a personalized neoantigen-based cancer vaccine. The trial focused on patients with non-small cell lung cancer, colorectal cancer, and gastroesophageal cancer. Fortrea's rigorous site selection, training, and logistics ensured successful patient recruitment, sample management, and regulatory submission, advancing the immunotherapy to Phase II-III. Key strategies included elite site activation, superior sample manag